Meek David D.
Insider CIK 1555337 · ECYT Chief Commercial Officer · MRTX Chief Executive Officer, Director · QURE Director · BXLT EVP and President, Oncology · ETTX Director · CGEM Director · FUSN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2026-06-16 | 2026-06-18 | 25,319 | — | $0 | 25,319 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2026-06-11 | 2026-06-12 | 1,993 | $27.06 | $53.9K | 39,747 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2026-06-10 | 2026-06-12 | 13,980 | — | $0 | 13,980 | SEC↗ |
| QURE uniQure N.V. | A Award | 2026-06-10 | 2026-06-12 | 7,550 | — | $0 | 41,740 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2025-06-20 | 2025-06-24 | 2,112 | $14.45 | $30.5K | 34,190 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2025-06-12 | 2025-06-16 | 38,513 | — | $0 | 38,513 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2025-06-11 | 2025-06-13 | 15,630 | — | $0 | 15,630 | SEC↗ |
| QURE uniQure N.V. | A Award | 2025-06-11 | 2025-06-13 | 7,970 | — | $0 | 36,302 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2024-06-19 | 2024-06-21 | 15,840 | — | $0 | 15,840 | SEC↗ |
| QURE uniQure N.V. | A Award | 2024-06-19 | 2024-06-21 | 8,080 | — | $0 | 28,332 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2024-06-13 | 2024-06-17 | 2,229 | $5.12 | $11.4K | 20,252 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 34,000 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2024-05-15 | 2024-05-16 | 15,618 | — | $0 | 15,618 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2023-10-16 | 2023-10-16 | 34,000 | — | $0 | 34,000 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-06-16 | 2023-06-20 | 2,290 | $18.85 | $43.2K | 22,481 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2023-06-13 | 2023-06-20 | 17,060 | — | $0 | 17,060 | SEC↗ |
| QURE uniQure N.V. | A Award | 2023-06-13 | 2023-06-20 | 8,700 | — | $0 | 24,771 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-02-27 | 2023-03-01 | 389 | $19.71 | $7.7K | 16,071 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 151,233 | — | $0 | 151,233 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 89,379 | — | $0 | 151,171 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2023-01-17 | 2023-01-19 | 3,179 | $42.38 | $134.7K | 61,792 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 4,616 | $40.41 | $186.5K | 64,971 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-12-19 | 2022-12-21 | 35,425 | — | $0 | 69,587 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 11,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 17,307 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer | 2022-07-11 | 2022-07-11 | 27,500 | $2.20 | $60.5K | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | U Tender | 2022-07-07 | 2022-07-11 | 22,000 | $2.20 | $48.4K | 0 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2022-06-15 | 2022-06-17 | 17,810 | — | $0 | 17,810 | SEC↗ |
| QURE uniQure N.V. | A Award | 2022-06-15 | 2022-06-17 | 9,080 | — | $0 | 16,460 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2022-02-28 | 2022-03-02 | 602 | $16.70 | $10.1K | 7,380 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2022-02-24 | 2022-02-28 | 2,645 | — | $0 | 2,645 | SEC↗ |
| QURE uniQure N.V. | A Award | 2022-02-24 | 2022-02-28 | 1,534 | — | $0 | 7,982 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2022-01-18 | 2022-01-19 | 27,500 | — | $0 | 49,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 56,433 | — | $0 | 56,433 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 34,057 | — | $0 | 34,057 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-09-22 | 2021-09-24 | 150,300 | — | $0 | 150,300 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 5,769 | — | $0 | 5,769 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 7,500 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 15,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-04-01 | 2021-04-02 | 22,000 | — | $0 | 22,000 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2021-03-02 | 2021-03-04 | 505 | $37.50 | $18.9K | 6,448 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2021-02-25 | 2021-03-01 | 4,107 | — | $0 | 4,107 | SEC↗ |
| QURE uniQure N.V. | A Award | 2021-02-25 | 2021-03-01 | 2,382 | — | $0 | 6,953 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2020-06-10 | 2020-10-06 | 11,000 | — | $0 | 11,000 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2020-02-27 | 2020-03-02 | 3,620 | — | $0 | 3,620 | SEC↗ |
| QURE uniQure N.V. | A Award | 2020-02-27 | 2020-03-02 | 2,063 | — | $0 | 4,571 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2020-01-28 | 2020-01-30 | 718 | $62.20 | $44.7K | 2,508 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2020-01-28 | 2020-01-30 | 4 | $60.94 | $244 | 3,226 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-06-19 | 2019-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-06-19 | 2019-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2019-01-25 | 2019-01-29 | 5,295 | — | $0 | 5,295 | SEC↗ |
| QURE uniQure N.V. | A Award | 2019-01-25 | 2019-01-29 | 3,230 | — | $0 | 3,230 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 191,421 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 43,334 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 54,553 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 6,155 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer | 2016-06-03 | 2016-06-07 | 51,640 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2016-03-03 | 2016-03-07 | 27,976 | — | $0 | 52,514 | SEC↗ |
| BXLT Baxalta Inc | F Tax w/h | 2016-03-03 | 2016-03-07 | 928 | $39.30 | $36.5K | 51,586 | SEC↗ |
| BXLT Baxalta Inc | F Tax w/h | 2015-09-02 | 2015-09-04 | 791 | $35.03 | $27.7K | 24,277 | SEC↗ |
| BXLT Baxalta Inc | J Other deriv | 2015-07-01 | 2015-07-06 | 43,334 | — | $0 | 43,334 | SEC↗ |
| BXLT Baxalta Inc | J Other deriv | 2015-07-01 | 2015-07-06 | 54,553 | — | $0 | 54,553 | SEC↗ |
| BXLT Baxalta Inc | A Award deriv | 2015-07-01 | 2015-07-06 | 191,421 | — | $0 | 191,421 | SEC↗ |
| BXLT Baxalta Inc | A Award deriv | 2015-07-01 | 2015-07-06 | 6,155 | — | $0 | 6,155 | SEC↗ |
| BXLT Baxalta Inc | J Other | 2015-07-01 | 2015-07-06 | 25,068 | — | $0 | 25,068 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2014-02-06 | 2014-02-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2014-02-06 | 2014-02-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ECYT ENDOCYTE INC | M Exercise deriv | 2013-09-12 | 2013-09-16 | 10,000 | — | $0 | 150,000 | SEC↗ |
| ECYT ENDOCYTE INC | M Exercise | 2013-09-12 | 2013-09-16 | 10,000 | $8.73 | $87.3K | 10,000 | SEC↗ |
| ECYT ENDOCYTE INC | S Sale | 2013-09-12 | 2013-09-16 | 10,000 | $15.50 | $155.0K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2013-02-19 | 2013-02-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2012-08-03 | 2012-08-07 | 160,000 | — | $0 | 160,000 | SEC↗ |